The latest Investing Matters Podcast episode with London Stock Exchange Group's Chris Mayo has just been released. Listen here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOctopus Aim 2 Regulatory News (OSEC)

Share Price Information for Octopus Aim 2 (OSEC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 43.40
Bid: 42.40
Ask: 44.40
Change: 0.00 (0.00%)
Spread: 2.00 (4.717%)
Open: 43.40
High: 43.40
Low: 43.40
Prev. Close: 43.40
OSEC Live PriceLast checked at -
Octopus AIM VCT 2 is an Investment Trust

To provide shareholders with attractive tax-free dividends and long-term capital growth by investing in a diverse portfolio of predominantly AIM-traded companies.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Interim Management Statement

20 Oct 2008 08:54

RNS Number : 1900G
Octopus IHT AIM VCT PLC
20 October 2008
 



Octopus (formerly CloseIHT AIM VCT plc ("Company" or "Fund")

20 October 2008

Interim Management Statement 

For the period from 1 June 2008 to 15 October 2008

In accordance with Rule 4.3 of the UK Listing Authority's Disclosure and Transparency rules, Octopus IHT AIM VCT plc presents an Interim Management Statement for the period 1 June 2008 to 15 October 2008, being the latest weekly valuation prior to the date of this statement.

Change of Manager

Shareholders will be aware that in the period covered by this report there has been a change to the corporate identity of the Company. Following the move by Andrew Buchanan and Kate Tidbury from Close investments Limited to Octopus Investments Limited, your Board agreed to novate the Management Agreement to Octopus Investments. As a result it was necessary to change the name of your Company which was approved at a General Meeting at the beginning of September. Shareholders existing share certificates have not been replaced and remain valid.

Financial Highlights 

As at 15 October 2008 

As at 30

September 2008

As at 31 

May 2008

As at 30 

November 2007

Net assets ('000)

£16,884

£17,929

£21,613

£23,518

Net asset value per share ("NAV")

67.6p

71.8p

86.5p

94.2p

Cumulative dividends paid since launch

5.4p

4.4p

4.4p

3.4p

Total return (NAV plus dividends paid)

73.0p

76.2p

90.9p

97.6p

Share price 

73.0p

73.0p

88.0p

94.0p

Premium/(discount) to NAV 

(8.0)%

1.7%

1.7%

(0.2)%

Investment Performance and Activity

Investors have faced a difficult time in the period covered by this report with significant turmoil in the stock market caused by the hiatus in the banking sector. The consequence has been a further reduction in share prices, most particularly amongst smaller companies, such as those this Venture Capital Trust ("VCT") invests in.  The total return, as a result, has fallen by 19.7between 1 May and 15 October. For the sake of comparison the FTSE AIM All Share Index has fallen by 53.5% between 1 June and 15 October and the FTSE SmallCap index by 31.9% in the same period.

Despite this market background not being conducive to flotations and further issues of new shares, this VCT has managed to make three new qualifying investments, totalling £2.1m. As at 15 October the fund is 65% invested in qualifying investments. It has until 30 November 2008 to reach the minimum 70% level required by HMRC regulations. With the current pipeline of opportunities your manager is confident of achieving this level. Following the change of manager outlined above, the reduction in the Close Special Situations Fund was accelerated and the final shares were sold in the period under review.

The total value of the AIM quoted investment portfolio at 15 October was £9.5m. These figures exclude cash holdings and are at bid prices.  

Ten largest holdings by value as at 15 October 2008

Company

Carrying value £'000

Percentage 

onet assets

IS Pharma 

753

4.6%

Research Now 

663

3.9%

Animalcare Group 

654

3.8%

Advanced Computer Software

618

3.7%

Pressure Technologies

577

3.4%

Tasty

550

3.3%

Essentaily

527

3.1%

Mount Engineering plc

499

3.0%

Clerkenwell Ventures plc

468

2.8%

Neuropharm plc

442

2.6%

Dividends 

As stated in the interim report for the 6 months ended 31 May 2008, a dividend of 1.0p per 'A' and 'B' Ordinary share was declared and this was paid to shareholders on 10 October 2008.

Buybacks 

During the period the Fund bought back 15,250 'A' Ordinary shares at a price of 70p per share. These are currently held in Treasury.

Total voting rights and capital

At the date of this announcement, the capital of the Company consists of 7,299,461 'A' Ordinary shares and 17,680,650 'B' Ordinary shares with a nominal value of 0.01 pence each, with voting rights. Octopus IHT AIM VCT plc holds 15,250 'A' Ordinary Shares in Treasury.

Therefore, the total number of voting rights in the Company plc is 24,964,861.

The figure of 24,964,861 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, Octopus IHT AIM VCT plc under the FSA's Disclosure and Transparency Rules.

Material events and transactions

The Board is not aware of any further material events or transactions between 15 October 2008 and the date of this report.

For further information please contact:

Andrew Buchanan/Kate Tidbury

Octopus Investments Limited 

Tel: 020 7710 2800

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSKGMZGNGMGRZG
Date   Source Headline
14th Dec 202211:27 amGNWNet Asset Value(s)
13th Dec 20225:35 pmGNWNet Asset Value(s)
12th Dec 20223:35 pmGNWNet Asset Value
1st Dec 20227:30 amGNWTotal Voting Rights and Capital
30th Nov 20222:55 pmGNWNet Asset Value(s)
22nd Nov 20224:51 pmGNWNet Asset Value(s)
17th Nov 20224:55 pmGNWPurchase of Own Securities and Total Voting Rights
17th Nov 202210:16 amGNWNet Asset Value(s)
15th Nov 20226:40 pmGNWIssue of Equity and Total Voting Rights
15th Nov 20224:25 pmGNWIssue of Equity and Total Voting Rights
14th Nov 20222:10 pmGNWIssue of Equity and Total Voting Rights
8th Nov 20224:00 pmGNWNet Asset Value(s)
25th Oct 20223:43 pmGNWNet Asset Value(s)
21st Oct 20225:37 pmGNWNet Asset Value(s)
14th Oct 20227:30 amGNWNet Asset Value(s)
13th Oct 202210:45 amGNWClose of Offers to Further Applications
11th Oct 20223:30 pmGNWNet Asset Value(s)
7th Oct 20224:30 pmGNWNet Asset Value(s)
6th Oct 202212:00 pmGNWOffer for Subscription - Over-Allotment Facility
30th Sep 20226:00 pmGNWTotal Voting Rights and Capital
28th Sep 20226:30 pmGNWNet Asset Value(s)
23rd Sep 20223:11 pmGNWNet Asset Value(s)
22nd Sep 202211:47 amGNWPublication of Prospectus
21st Sep 20224:00 pmGNWPortfolio Update
16th Sep 202211:00 amGNWPurchase of Own Securities and Total Voting Rights
14th Sep 20227:30 amGNWNet Asset Value(s)
12th Sep 20225:45 pmGNWNet Asset Value(s)
9th Sep 20227:30 amGNWNet Asset Value(s)
1st Sep 20226:13 pmGNWNet Asset Value(s)
1st Sep 20226:10 pmGNWTotal Voting Rights and Capital
1st Sep 20226:09 pmGNWPurchase of Own Securities and Total Voting Rights - Replacement
25th Aug 20223:59 pmGNWNet Asset Value(s)
18th Aug 20225:15 pmGNWPurchase of Own Securities and Total Voting Rights
17th Aug 20222:30 pmGNWNet Asset Value(s)
15th Aug 20228:00 amGNWIssue of Equity and Total Voting Rights
9th Aug 20225:30 pmGNWNet Asset Value(s)
5th Aug 20227:30 amGNWNet Asset Value(s)
4th Aug 20227:30 amGNWNet Asset Value(s)
1st Aug 20225:00 pmGNWTotal Voting Rights and Capital
28th Jul 20221:00 pmGNWPurchase of Own Securities and Total Voting Rights - Replacement
27th Jul 20226:25 pmGNWPurchase of Own Securities and Total Voting Rights
26th Jul 20222:10 pmGNWNet Asset Value(s)
25th Jul 20221:00 pmGNWIntention to Fundraise
22nd Jul 20223:15 pmGNWHalf-Yearly Results
19th Jul 20226:41 pmGNWNet Asset Value(s)
18th Jul 20225:00 pmGNWNet Asset Value(s)
14th Jul 20225:45 pmGNWNet Asset Value(s)
11th Jul 20224:00 pmGNWNet Asset Value(s)
1st Jul 20227:00 amGNWTotal Voting Rights and Capital
29th Jun 20226:15 pmGNWNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.